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A B S T R A C T
A new modeling method to evaluate multiple compositions' bioactive contribution against the whole traditional
Chinese medicine (TCM) extracts was presented and a real sample experiment was carried out for
demonstration. The quantitates and antioxidant eﬀects of diﬀerent DanShen extracts and 13 chemical
components were evaluated and evolved in the model by curve ﬁtting and least square optimization. From
the model, each component's bioactivity was predicted and the individual contribution over the whole
antioxidant activity was calculated also. These data will provide valuable guides for ﬁnding new potential
bioactive component in TCM.
1. Introduction
Natural product related drugs have attracted more and more
attention of clinical doctors, patients and researchers for new drug
development all over the world. Traditional Chinese medicine (TCM) is
a special category of natural products among herbal because of its long
clinical history and systemic medicine theories. Many TCM herbals
have been validated eﬀective deﬁnitely by physicians and researchers.
Finding new drug candidates from natural products has been an
eﬀective and eﬃcient way for researchers [1].
However, there are still some obstacles not resolved well in new
drug development. One of them is how to evaluate, compare the
bioactive eﬀects and contributions of compositions and then target
drug candidate from medicinal herbals. There are thousands of
chemical constituents in an herbal plant and among which there maybe
hundreds of chemicals with similar structure group related with a
speciﬁc bioactivity. The classic discovery procedure, chemical analyz-
ing, isolating, purifying and bioactivity evaluating, which might cost a
lot of time and ﬁnancials, seemed not to be an eﬃcient solution. Some
comprehensive procedures combined chemical analysis, bioactivity
screening, well-designed experiments and multivariate modeling has
been presented more and more in natural product research.
In this paper, a novel modeling method was presented to evaluate
the antioxidant bioactivity of several similar-structure constituents in a
TCM (Salvia miltiorrhiza Bge., DanShen) [2] and provided a real
experiment sample for validation. DanShen is a well-known and widely
used traditional Chinese medicine in China and is accepted more and
more by other countries. A patented product, Compound Danshen
Dripping Pill (also referred to as Cardiotonic Pill), which contains the
extract of the root of Danshen, has successfully completed Phase II
clinical trials in United States following FDA requirements. In the
sample experiment, the antioxidant activities of several chemical
constituents, including protocatechuic acid (CAS: 99-50-3), protocate-
chuic aldehyde (CAS: 139-85-5), caﬀeic acid (CAS: 331-39-5), ferulic
acid (CAS: 1135-24-6), rosmarinic acid (CAS: 537-15-5), tanshinone
IIA (CAS: 568-72-9), cryptotanshinone (CAS: 35825-57-1), lithosper-
mic acid (CAS: 28831-65-4), salvianolic acid B (CAS: 121521-90-2),
salvianolic acid A (CAS: 96574-01-5), danshensu (CAS: 76822-21-4),
dihydrotanshinone I (CAS: 87205-99-0) and tanshinone I (CAS: 568-
73-0), were evaluated by DPPH and ABTS tests. Vitamin C served as
positive reference. All these chemicals were known to have antioxidant
activities and existed in DanShen plants. And these chemicals were
regarded as the bioactive components in DanShen as to the antioxidant
eﬀect. Then the question was how to evaluate each component's
contribution on antioxidant eﬀect over the whole 13 chemicals coex-
isted in DanShen extracts with diﬀerent concentrations. The compo-
nent's contribution information on a speciﬁc bioactivity would be very
useful for the further target-guided drug development.
2. Theory
This section provided a brief description on the modeling method.
The whole procedure could be determined as two parts: modeling for a
single component and modeling for multiple components.
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2.1. Bioactivity model for a single component
A classical sigmoid curve model from pharmacological dose –
response relationship was applied to ﬁt the dose – response curve of
extracts and single component. The extracts were also regarded as a
single chemical component as a whole.
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In the above equation D was dosage and γ was shape index. ED50
was the dosage when response E reached a half of maximum response
Emax.
2.2. Equivalent dosage transformation
In natural product extracts there were much components coexisted,
which might be bioactive, more or less. For question simpliﬁcation, the
interactions among components were ignored and in the result section
it would be veriﬁed that the interactions were very little even existed.
Then an assumption was proposed that the mathematical sum of each
component's bioactivity function should be equal to the whole extract's
bioactivity. However, the bioactivity data could not be added up
together directly. So an intermedia concept, equivalent dose, was
introduced for bioactivity sum up and comparison among components.
If a component A at dose DA had the same bioactive response with
the reference drug R at dose DR, A at DA was thought bioequivalent
with R at DR. Then the response of A at DA could be expressed as the
equivalent dose DR of reference drug R (usually positive reference).
The equation deduction was as follows.
E E D
ED D
E D
ED D
=
+
=
+
A
γ
A
γ
A
γ
R
γ
R
γ
R
γmax
50,
max
50,
A
A A
R
R R (2)
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
D
ED
D
ED
=A
A
γ
R
R
γ
50, 50,
A R
(3)
Through the above equations, each component's bioactivity could
be transformed to bioactivity of reference drug R at a series of doses
with known parameters ED50 and γ, correspondingly. Then the natural
product extract containing multiple components could be regarded as
diﬀerent part of single reference drug at diﬀerent doses bio equiva-
lently. The doses of reference drug obviously could be added up to
represent the total bioactive strength of extracts and each component's
bioequivalent dose could be regarded as its contribution to the whole
bioactivity. The bioactivity strength of extracts could be expressed as
follows:
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In which DRi was the ith component's bioequivalent dose to
reference drug R.
2.3. Nonlinear ﬁtting and least square optimization
In Eq. (4), Ewhole, γR and ED50, R could be got by experiment tests
and DRi was unknown. From Eq. (3), DRi could be calculated by ED50i
and γi for each component. And from Eq. (1), a dose – response curve
could be got completely by ED50i and γi. So the next step was to
evaluate ED50i and γi for the ith component by mathematical computa-
tion. Here least square optimization was applied with trust-region
method. The objective function was set as the diﬀerence square of
antioxidant eﬀect between evaluated and determined by experiments.
That was:
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In Eq. (5), DRi could be substituted according to Eq. (3) and the
parameters ED50, i and γi for each component could be got by
optimization search. Then from the two critical parameters ED50, i
and γi, the eﬀect of each component and its contribution to the whole
extract could be evaluated easily.
3. Experimental
3.1. Herbal extracts preparation
To get a good data set with as large variable variation as possible for
modeling, the whole plant of DanShen besides its roots, the traditional
organs for medicine, was selected, which was harvested at diﬀerent
months. By diﬀerent plant parts, harvest time and extract methods all
the samples were divided into 6 groups: SY-7 and SY-12, the stems and
leaves of DanShen harvested at June and December extracted by water,
SG, the roots of DanShen harvested at December extracted by water,
CY-7, CY-12 and CG, the ethanol extracts of stems and leaves got at
June and December and roots at December correspondingly. All the
extract samples were vacuumed concentrated and vapored to dry.
3.2. Quantity determination
All the samples were resolved and diluted to suitable concentrations
according to the original weights of dry plants. Then the samples were
analyzed by an UPLC-triple quadrupole mass spectrometry on a
ACQUITYTM UPLC BEH C18 column. The 13 MRM functions were
applied for all the known components respectively. The method was
veriﬁed to be enough sensitive, linear and precise.
3.3. Bioactivity assay
The classical DPPH (2,2-diphenyl-1-picrylhydrazyl) [3] and ABTS
(2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid)) [4] assay
methods were applied to obtain the antioxidant data for all the 6
group samples. The cleaving ratios were calculated as the ﬁnal data set
for modeling for the two assays.
3.4. Modeling and optimization
All the calculations were carried out by self-written scripts under
Matlab R2015b environment with the help of statistic and optimal
toolboxes. All the codes were welcome for tests and referenced on
demand.
4. Results and discussions
4.1. The dose – response model for single component
Eq. (1) was used to describe the dose – response curve for single
component. This equation was the basis for the following modeling and
optimization. For veriﬁcation four components were selected and their
bioactivity data were obtained by standard pure references for model
ﬁtting. Fig. 1 showed that the four representatives ﬁtted Eq. (1) very
well.
4.2. The dose – response model for extracts
The percentage concentrations of 13 components were got by
UPLC-MS determination. It was found that the sum up of quantities
of 13 components took up only about 10% of the whole herbal extracts.
From the assumption the bioactivity of extracts should be only from the
13 components and be their sum up. To verify the assumption, the dose
– response curve for every extracts was built by the bioactive data and
dose of the extracts as Section 4.1. Fig. 2 showed that all the extracts
were ﬁtted well. That meant the unknown parts in the extracts should
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have no antioxidant bioactivities.
4.3. The optimization and component's bioactivity contribution
The optimization method was applied to solve Eq. (5). Based on the
evaluated values of ED50 and γ, each component's bioactivity could be
evaluated at any dose. According to Eq. (2), each component's
contribution could be evaluated by the percentage of corresponding
reference dose in an extract. Fig. 3 showed the heat map of all
components' bioactive contributions. From Fig. 3, the real important
component with strong antioxidant bioactivity could be selected out
easily.
From Fig. 3, it was easily found that salvianolic acid A was the most
important bioactive component and caﬀeic acid, rosmarinic acid,
protocatechuic acid, and lithospermic acid had little contribution.
These unimportant components might be discarded in the next new
drug development.
5. Conclusion
From the above quantitative analyzing, bioactivity assay and
mathematical modeling procedure, the question of ﬁnding eﬀective
and valuable components in natural herbal extracts was solved easily
and well. Although the ﬁnal results must be veriﬁed again by real
experiment, which was omitted in this paper, the proposed procedure
provided a large amount of useful information for the following new
drug development research. Compared with the classical experimental
new drug discovery, the new procedure was more rapid, more
economical and more informal. It was worthable to be introduced into
other natural product development.
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